Evaluation for Friday, 20th of August
| 9:00 – 9:30 | Plenary Lecture 2: Cancer immunotherapyDaniel Speiser, (Lausanne, CH) | |
T cell receptor gene therapy Thomas Blankenstein (Berlin, D) | ||
| 10:00 – 11:30 | Symposium 3a: Clinical ImmunologyVaccination Martin Bachmann, (Bern, CH) / Steve Pascolo, (Zurich, CH) | |
Preclinical development of vaccine candidates against COVID-19 Martin Bachmann (Bern, CH) | ||
YF17D-based vaccines against COVID-19 and other emerging infections Kai Dallmeier (Leuven, BE) | ||
Abstract Talk (OP2)HLA-DRB1*04 associated chronic inflammation and extracellular matrix-specific autoimmunity following inadvertent periarticular influenza vaccination Julia R. Hirsiger (Basel CH) | ||
Abstract Talk (OP24)PD-L1 Incorporation within HIV Virions Contribute to Functionally Impair T-Follicular Helper Cells Olivia Munoz (Lausanne CH) | ||
| 10:00 – 11:30 | Symposium 3b: Clinical ImmunologyLindenmann symposium for innate immunity Otto Haller, (Zurich, CH) / Stéphanie Hugues, (Geneva, CH) | |
NK cell-mediated recognition of virus-infected cells Marcus Altfeld (Hamburg, D) | ||
Stroma-macrophage interactions Marc Bajénoff (Marseille, F) | ||
Abstract Talk (OP8)Autophagy proteins in the restriction of Kaposi’s Sarcoma-Associated Herpesvirus Entry Katarina Schmidt (Zurich CH) | ||
Abstract Talk (OP18)Multisystem Inflammation and Susceptibility to Viral infections in Human ZNFX1 Deficiency Stefano Vavassori (Zurich CH) | ||
| 10:00 – 11:30 | Symposium 3c: Clinical ImmunologyNovel biologics in immunotherapy Thomas Hauser, (Zurich, CH) / Onur Boyman, (Zurich, CH) | |
Mitochondria dynamics tailor T cell anti-tumor immunity Ping-Chih Ho (Lausanne, CH) | ||
Immunotherapy with Gene Engineered T Cells Hans Stauss (London, UK) | ||
Abstract Talk (OP1)Development of a compartment locked IL-12 version with increased tissue retention and minimal peripheral exposure for local glioblastoma therapy Linda Schellhammer (Schlieren CH) | ||
Abstract Talk (OP6)Anti-CD20 rituximab IgG1, IgG3 and IgG4 but not IgG2 subclass differentially trigger Ca2+ mobilization and cytotoxicity in human NK cells Marta Freitas Monteiro (Geneva CH) | ||
| 12:15 – 13:00 | Company Symposium | |
Familial mediterranean fever (FMF) - behind the sceneMore than just fever: diagnosis and standard treatment of FMF / How to treat patients with FMF and amyloidosis Dr. med. Tatjana Welzel University Children's Hospital Basel (UKBB), Switzerland / Prof. Dr. med. Norbert Blank University Hospital Heidelberg, Germany | ||
| 13:15 – 14:45 | Symposium 4a: Basic ImmunologyZinkernagel symposium on anti-viral immunology Manfred Kopf, (Zurich, CH) / Annette Oxenius, (Zurich, CH) | |
Mechanisms of CD8 T cell immunity and pathology Dietmar Zehn (Freising, D) | ||
Functional biology of hepatic CD8+ T cells Matteo Iannacone (Milan, I) | ||
Abstract Talk (OP13)Human tissue resident memory T cells arise during Epstein Barr virus infection in a humanized mouse model Daniel Kirchmeier (Zurich CH) | ||
Abstract Talk (OP15)Viral Infections License CD4+ T Cells for Antigen‐Independent Recruitment and Activation Nima Yassini (Zurich CH) | ||
| 13:15 – 14:45 | Symposium 4b: Basic ImmunologyTumor immunology Pedro Romero, (Lausanne, CH) / Mitchell Levesque, (Zurich, CH) | |
Targeting Regulatory T Cells in Cancer: Means and Mechanism Sergio Quezada (London, UK) | ||
Immunoregulation and the tumor microenvironment Pamela Ohashi (Toronto, CA) | ||
Abstract Talk (OP20)Isocitrate dehydrogenase 2 inhibition induces memory CD8+ T cells with enhanced antitumor function Alison Jaccard (Epalinges CH) | ||
Abstract Talk (OP21)Bedside formulation of a personalized multi-neoantigen vaccine against mammary carcinoma Mona Mohsen (Bern CH) | ||
| 13:15 – 14:45 | Symposium 4c: Clinical ImmunologyMicrobiota Wolf-Dietrich Hardt, (Zurich, CH) / Emma Slack, (Zurich, CH) | |
The diversity and specialty of intestine mucosal antibody responses Andrew Macpherson (Berne, CH) | ||
Gut microbiota mediated regulation of neuroinflammation Gurumoorthy Krishnamoorthy (Martinsried, D) | ||
Abstract Talk (OP12)Epithelium-autonomous NAIP/NLRC4 prevents TNF-driven inflammatory destruction of the gut epithelial barrier in Salmonella-infected mice Stefan Fattinger (Zurich CH) | ||
Abstract Talk (OP19)Aryl hydrocarbon receptor (AhR) signaling in the host response directed against the skin commensal yeast Malassezia during health and disease Eduardo Gushiken Ibañez (Zurich CH) | ||
| 16:15 – 17:00 | Plenary Lecture 3: Anti-viral ImmunityChristian Münz, (Zurich, CH) | |
Antibody-mediated neutralization of SARS-CoV-2 Florian Klein (Cologne, D) |
Edit